Document is current
Any future updates will be listed below
-
Authors
Wang, Junke
Yang, Jie
Narang, Amol
He, Jin
Wolfgang, Christopher
Li, Keyu
Zheng, Lei
-
Funding
Funding for this research was provided by:
Science and Technology Department of Sichuan Province (2023YFS0167, 2024NSFSC1949)
Postdoctor Research Fund of West China Hospital, Sichuan University (2023HXBH053, 2024HXBH134)
National Natural Science Foundation of China (82303740, 82403318)
China Postdoctoral Science Foundation (2023T160451)
National Institutes of Health (R01 CA169702, R01 CA197296, P01 CA247886, P50 CA062924, P30 CA006973.)
- License Information
-
More Information
Article History
Received: 16 August 2024
Accepted: 25 September 2024
First Online: 10 October 2024
Declarations
:
: Not applicable.
: L.Z. receives grant support from Bristol-Meyer Squibb, Merck, AstraZeneca, iTeos, Amgen, NovaRock, Inxmed, Halozyme and Abmeta. L.Z. is a paid consultant/Advisory Board Member at Biosion, Alphamab, NovaRock, Ambrx, Akrevia/Xilio, QED, Novagenesis, Snow Lake Capitals, Amberstone, Pfizer, Tavotek, and Mingruizhiyao. L.Z. holds shares at Alphamab, Amberstone, Mingruizhiyao, and Cellaration. LZ is an editorial board member of Journal of Hematology and Oncology.
